Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244234 (US9428501, 58) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.860 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244236 (US9428501, 69) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244233 (US9428501, 57) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.80 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244235 (US9428501, 66) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.80 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244223 (US9428501, 18) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244237 (US9428501, 79) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.30 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244226 (US9428501, 35) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.60 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244227 (US9428501, 36) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.10 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244230 (US9428501, 44) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.20 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244231 (US9428501, 49) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.5 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244220 (US9428501, 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.30 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244228 (US9428501, 37) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244224 (US9428501, 19) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 10 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244221 (US9428501, 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244229 (US9428501, 38) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244232 (US9428501, 50) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 14 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244225 (US9428501, 23) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 19 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244219 (US9428501, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 24 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM244222 (US9428501, 14) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 34 | n/a | n/a | n/a | 37 |
Astellas Pharma Inc. US Patent | Assay Description In order to make MDA-MB-453 cell become 15000 cells per well, each 36 μl was seeded in Leibovitz's L-15 medium including 10% fetal bovine serum (m... | US Patent US9428501 (2016) BindingDB Entry DOI: 10.7270/Q28051JK | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327862 (N-(4-(4- cyanobenzyl)piperadin- 4-yl)-6-(4-(4- flu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327868 (N-(1- (cyclohexanecarbonyl) piperidin-4-yl)-5-(4-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327869 (N-(1-(benzoyl)piperidin- 4-yl)-5-(4-(4- fluorobenz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327870 (N-(1-(4-cyanobenzyl)- 1H-pyrazol-3-yl)-5-(4- (4- f...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327871 (N-(4-benzylphenyl)-5- (4-(4- fluorobenzyl)piperazi...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327872 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl-N-(4-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327877 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327879 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327882 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(3...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327883 ((6-(3- (benzyloxy)phenyl) pyridin-3-yl)(4-(4- flu...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327884 (N-(1-(4-cyanobenzyl)- 1H-pyrazol-4-yl)-5-(4- (4- f...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327885 (N-(4-(4- cyanophenyl)phenyl)-5- (4-(4- fluorobenzy...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327886 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327887 (N-(4-benzoylphenyl)-5- (4-(4- fluorobenzyl)piperaz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327892 (4-((2-(5-(4-(4- fluorobenzyl)piperazine- 1-carbony...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327906 (N-(4-(4- cyanobenzylcarbamoyl) phenyl)-5-(4-(4- f...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327908 (N-(1-(3,5- difluorobenzyl)piperidin- 4-yl)-5-(4-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327909 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327910 (N-(1-(4- chlorobenzyl)piperidin- 4-yl)-5-(4-(4- fl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327911 (N-(1-(4- chlorobenzyl)piperidin- 4-yl)-5-(4-(4- fl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327912 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327913 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327914 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327915 (N-(4-(3- cyanophenoxy)phenyl)- 5-(4-(4- fluorobenz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327916 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327917 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327918 (N-(4-(4- cyanophenoxy)phenyl)- 5-(4-(4- fluorobenz...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327919 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327920 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327921 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-N-(4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
5'-AMP-activated protein kinase catalytic subunit alpha-2 (Homo sapiens (Human)) | BDBM327922 (5-(4-(4- fluorobenzyl)piperazine- 1-carbonyl)-(6-(...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <500 | n/a | n/a | n/a | n/a |
Rigel Pharmaceuticals, Inc. US Patent | Assay Description Compounds were assayed for their ability to activate AMPK using an enzyme-linked immunosorbent assay. Reagents and procedures for measuring AMPK acti... | US Patent US9663496 (2017) BindingDB Entry DOI: 10.7270/Q26975P8 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 1007 total ) | Next | Last >> |